CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Forendo has announced pharma licensing deal with Apricus

October 21, 2014 : partnering, pharma licensing, pharma partners

Forendo Pharma has entered into a definitive pharma licensing deal for the US development and commercialization rights for fispemifene to Apricus Biosciences. more »

NewLink Genetics signs a $1 billion pharma deal with Genentech

October 21, 2014 : big biotech, big pharma, Genentech

NewLink Genetics has inked a pharma deal potentially worth $1 billion with Genentech for the development of NLG919, NewLink’s IDO pathway inhibitor. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Morphosys acquires lanthipeptide technology from Lanthio Pharma

October 16, 2014 : acquisition, asset purchase, big biotech, MorphoSys, technology

MorphoSys and Lanthio Pharma acquires of Lanthio Pharma’s lanthipeptide technology, which will be used for drug discovery by MorphoSys. more »

Roche has acquired a cancer drug for $65.8 million

October 15, 2014 : acquisition, asset purchase, cancer, Roche

Roche has acquired from Wilex the rights to an undisclosed cancer drug for as much as $65.8 million. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Canaan Partners raise $675 million in fundraising financing

October 20, 2014 : financing, financings

Canaan Partners announced yesterday the creation of a new financing worth $675 million, dubbed Canaan X. more »

Highland gets $25 million from common shares financing

October 17, 2014 : financing, financings

Highland Therapeutics has completed a US$25 million offering of Class A Common Shares. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

AbbVie rethinking the $54 billion acquisition of Shire

October 16, 2014 : AbbVie, acquisition, shire

In response to recent changes to the U.S. tax code to discourage so-called tax inversion deals, Chicago-based AbbVie recently indicated it was rethinking its $54 billion takeover bid of U.K.-based Shire. more »

Actavis chasing Allergan also…which way will Allergan go?

October 15, 2014 :

Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday. more »

 More dealtalk

Featured reports

Global Joint Venture Partnerships

Publication date: October 2014

Top 50 Big Pharma Partnering and M&A

Publication date: October 2014

Bioinformatics Partnering Terms and Agreements

Publication date: October 2014

Top 50 Big Biotech Partnering and M&A

Publication date: October 2014

Molecular Diagnostics Partnering Terms and Agreements

Publication date: October 2014

Regenerative Medicine Partnering Terms and Agreements

Publication date: October 2014

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
bannerpng
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
e56300x150animgif
beu14banner300x150jpg